logo-loader
viewInnovaDerma PLC

InnovaDerma reports strong cash and 'resilient performance' during pandemic

InnovaDerma PLC's (LON:IDP) chairman Joe Bayer and CEO Kieran Callan tell Proactive London's Andrew Scott the business has performed resiliently during the coronavirus pandemic lockdown but have been hit by rising advertising costs. Bayer says they now want to start swinging the earnings pendulum towards bridging the gap between first and second half seasonality impacts and adds they're looking for more growth. ''We're focused and have come through the worst of it and are looking for a better future''.

Quick facts: InnovaDerma PLC

Price: 62 GBX

LSE:IDP
Market: LSE
Market Cap: £8.99 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of InnovaDerma PLC named herein, including the promotion by the Company of InnovaDerma PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

InnovaDerma 'well-positioned' with a strong pipeline of new products and...

InnovaDerma PLC's (LON:IDP) Joe Bayer and Kieran Callan talk Proactive London's Andrew Scott through their half year report as well as updating on new products and plans. In its results statement covering the six months to the end of 2019, the developer of beauty, personal care and life...

on 27/2/20

2 min read